Health X Platform Ltd · NSE:HEALTHX

Health X Platform — Sastasundar Ventures — Corporate Update (December 2021)

17 slides from Health X Platform's corporate update, Dec 14, 2021

  1. Slide 1: Regulation 30 intimation letter to stock exchanges

    SASTASUNDAR VENTURES LIMITED Azimganj House, 2nd Floor, 7 Abanindra Nath Thakur Sarani (Formerly Camac Street), Kolkata 700017, India. Tel: +91 33 2282 9330; Fax: +91 33 2289 9335 Email: info@sastasundar.com; Website: Www.Sastasundarventures. com CIN: L65993WB1989PLC047002 Date: 14-12-2021 To To The

  2. Slide 2: Sastasundar Ventures Ltd. (SVL) Investor's Update

    Ventures Ltd.(SVL) INVESTOR’s UPDATE 1

  3. Slide 3: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sastasundar Ventures Limited (the “Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any

  4. Slide 4: Existing Corporate Structure (Only Relevant Entities)

    Existing Corporate Structure (Only Relevant Entities) Mitsubishi Corporation SastaSundar Ventures Ltd.(SVL) & Rohto Pharmaceuticals 72% 28% SastaSundar Healthbuddy Limited (SHBL) Wholesale business to support Flipkart Health Pvt. Ltd. Seller Pharmacy Network of SastaSundar.Com 75.1% 100% 100% 24.9%

  5. Slide 5: Update

    Update 1. SML has received the amount of INR 372.00 crores from Flipkart Health Private Limited on account of allotment of equity shares of SML to Flipkart Health Private Limited; (holding 75.1% of Equity share capital of SML) 2. SHBL has also received INR 689.76 Crores from Flipkart Health Private

  6. Slide 6: Future Macro Strategy

    Future Macro Strategy Focus & Growth ‘Digital Platform of Healthcare’ Pharmacy Wellness Diagnostic Develop Leverage Deliver 3T 2C 3C Team Consumer Base Cash Flow Technology Capital Customer Experience Trust Community Wellbeing 5

  7. Slide 7: Future Micro Strategy

    Future Micro Strategy B2C Platform B2B Platform Genu Path Labs • Expand & Grow network of • Expand – PAN India, Accelerate • Expand Diagnostic Network in Seller Pharmacies – PAN India growth Eastern India • Expand fulfilment • Leverage scale to Maximise • Leverage consumer base of capabilities – PAN

  8. Slide 8: SastaSundar: health & happiness

    639SastaSundar: health & happiness

  9. Slide 9: Registered users, health buddies and orders growth

    ~90% orders from repeat customers* No. of Registered 4.29 Users (in. Mn) 3.72 6x 2.65 1.33 0.66 FY18 FY19 FY20 FY21 H1FY22 29.5% product margin on medicines 458 489 2x No. of HBs (in. Nos) 299 390 1.6% returns (as a % of GMV)* 205 FY18 FY19 FY20 FY21 H1FY22 INR 870 average order value* No. of Orders

  10. Slide 10: RetailerShakti app screens

    = WRetailerShakti > A & High ergine Prodacts 50,00 52,000 * ,00¢ Household Medicine e Products Offers and Deals & £ FF cial offer «Pee Prosucts Offer on Brands Spacial Ofer foe Shop ty Brand Shopby Category + @ a B Sheet Request kg Retailer Shakti

  11. Slide 11: Who we are / Value we provide to Retailers

    Who we are Digital Platform (App + Website) to empower Retailers (B2B) – Pharma, Wellness, FMCG, Beauty Care, Cosmetics etc. Value we provide to Retailers Availability and Fulfilment Timely Delivery Genuine High Margin with of all Products at Shops Products Transparent Pricing (52000+ Products) Secu

  12. Slide 12: Transforming Economics & Lives of Retailers

    Transforming Economics & Lives of Retailers Conventional Distribution Channels Impact on Retailers • Reduction of Inventory Time • Multiple Distributor • Next Day Delivery at One Click • Availability increases Supply Time – 15 to 30 Days • Capital Employed Reduced • Higher Margin • Pricing are not o

  13. Slide 13: Genu Path Labs

    SGENU |-ccurcr, @NABL PATH LABS | GUARANTEED

  14. Slide 14: Genu Path Labs: NABL accredited lab network

    Genu Path Labs, an NABL ACCREDITED LAB, where everything revolves around Meticulous Assay of Quality Evidence. Highly experienced Clinical Team, Advanced High End Lab Equipment, Stringent Quality Norms – EQAS, ILC, Strong Process Control (QuaGenLR) – we employ all 30+ Sample Collection Centres acros

  15. Slide 15: Our Core Value, Our Culture

    Our Core Value Sundar: & happiness Nothing can be more Genuine than our Mothers’ Love BEING GENUINE OUR CORE VALUE Being Genuine in Conduct, Communication & Dealings SastaSundar: health & happiness Our Culture Ee NE CHILD IS OUR CULTURE Like Child- ‘Innovate’, ‘Don’t Discriminate’, ‘Connect Emotiona

  16. Slide 16: Recognitions

    Recognitions il “nae, sw ee eT YI ane 3” We 3” “E Byrn » 5 Bre tare teers | 5 Witectresnectons | ee. centers rt f ate As eS: apa tettert Certificate oie a OF RECIATION October 1, 2021 pee: a ... ‘We are pleased to announce ‘We are pleased to announce ‘MyGou Congratulates Sastasundar Marketplace Limi

  17. Slide 17: Thank You

    Contact Information Thank You For Further Information, please contact: Company: Investor Relations Partner: Sastasundar Ventures Limited Orient Capital (a division of Link Group) CIN: L65993WB1989PLC047002 Payal Dave Mr. Pratap Singh – Company Secretary payal.dave@linkintime.co.in Email ID: p_singh@

Sastasundar Ventures — Corporate Update (December 2021) on 6ix